This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Renee F. Slobasky
Chair & Senior Vice President
Contact
reneeslobasky@westat.comOverview
Renee Slobasky is Chair of the Westat Board of Directors and a Senior Vice President. In her more than 40-year career at Westat she has had a major organizational role in developing Westat’s national survey capability for conducting large-scale data collection. She has coordinated policy and standards for fieldwork across all Westat study groups and provided oversight to the development of Westat’s field staff across the country.
Slobasky has 40 years of experience in project management, planning, design, and field management for large-scale national data collection projects. Over the years she has directed some of Westat’s largest projects.
Education
- MS, Sociology, American University
- BA, Sociology, American University
Areas of Expertise
Data Collection-
Associations between biomarkers of nicotine/tobacco exposure and respiratory symptoms among adults who exclusively smoke cigarettes in the U.S.: Findings from the PATH Study Waves 1–4 (2013–2017)
17,
Addictive Behaviors Reports
January 2023
K.C. Edwards, J.E. Ozga, C. Reyes-Guzman, D. Smith, D. Hatsukami, J.L. Hart, A. Jackson, et al.
DOILink for: Associations between biomarkers of nicotine/tobacco exposure and respiratory symptoms among adults who exclusively smoke cigarettes in the U.S.: Findings from the PATH Study Waves 1–4 (2013–2017) -
Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during Omicron BA.4 and BA.5 sublineage periods
6,
JAMA Network Open
January 2023
R. Link-Gelles, M.E. Levy, K. Natarajan, S.E. Reese, A.L. Naleway, S.J. Grannis, N.P. Klein, et al.
DOILink for: Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during Omicron BA.4 and BA.5 sublineage periods -
Cardiovascular outcomes among combustible-tobacco and electronic nicotine delivery system (ENDS) users in Waves 1 through 5 of the Population Assessment of Tobacco and Health (PATH) Study, 2013-2019
19,
International Journal of Environmental Research and Public Health
January 2022
M.C. Mahoney, C. Rivard, H.L. Kimmel, H.T. Hammad, E. Sharma, M.J. Halenar, J. Sargent, et al.
DOILink for: Cardiovascular outcomes among combustible-tobacco and electronic nicotine delivery system (ENDS) users in Waves 1 through 5 of the Population Assessment of Tobacco and Health (PATH) Study, 2013-2019